Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers

We began analyzing https://link.springer.com/article/10.1007/s12282-016-0732-1, but it redirected us to https://link.springer.com/article/10.1007/s12282-016-0732-1. The analysis below is for the second page.

Title[redir]:
Recent development of targeted approaches for the treatment of breast cancer | Breast Cancer
Description:
Breast cancer is the most prominent cause of cancer death in women worldwide. The highlights of this review are to provide an overview of the targeted therapeutic agents, challenges with metastatic breast cancer (MBCa), mechanisms of action through Hedgehog/Gli 1 signaling pathway and future prospective. Over a decade of success, several drugs have been approved and are in the advanced stages of clinical trials that target the receptors such as estrogen receptor, growth factor receptor, receptor activator of nuclear factor kappa-B, etc. Currently, several monoclonal antibodies are also used for the treatment of breast cancer. Advances in understanding tumor biology, particularly signaling pathways such as Notch signaling pathway, Hedgehog/Gli 1 signaling pathway, and inhibitors are considered to be important for bone metastasis. These studies may provide vital information for the design and development of new strategies with respect to efficacy, reduction of the side effects, and treatment strategies.

Matching Content Categories {πŸ“š}

  • Health & Fitness
  • Education
  • Science

Content Management System {πŸ“}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {πŸ’Έ}

We can't tell how the site generates income.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Doi.org might be making money, but it's not detectable how they're doing it.

Keywords {πŸ”}

cancer, pubmed, breast, article, google, scholar, cas, receptor, signaling, res, central, treatment, phase, estrogen, oncol, metastatic, pathway, therapy, clin, advanced, growth, targeted, patients, trial, therapeutic, factor, study, med, randomized, review, target, inhibitors, postmenopausal, iii, privacy, cookies, content, data, development, maruthanila, women, clinical, metastasis, chem, int, cell, oral, selective, information, publish,

Topics {βœ’οΈ}

igf-1r/p-akt signaling pathway hormone-receptor-positive breast cancer month download article/chapter newly-discovered molecular mechanisms growth factor receptor bristol-myers squibb experience 2-oxo-3-aryl-chromen-4-yl her2-positive breast cancer ro4929097 gamma-secretase inhibitor class cdk4/cdk6 inhibitor immunosuppressive a-pyrone diterpenoid pp2a-dependent akt pathway anti-breast cancer potential estrogen receptor signaling hedgehog/gli pathway related subjects estrogen receptor pathway estrogen receptor antagonist full article pdf hedgehog signaling pathway nuclear factor kappa vegf targeted agent anthracycline/taxane-based chemotherapy metastatic breast cancer early breast cancer combination targeted therapy privacy choices/manage cookies pi3k/akt signaling randomized controlled trials anti-angiogenic therapy notch signaling pathway cancer treat rev anti-cancer immunotherapy phase ii study breast cancer metastasis cilengitide inhibits progression targeted therapeutic agents invasive breast cancer invasive breast cancer primary tumor growth pi3k/akt pathway lee yh mol cancer ther breast cancer res clin breast cancer signal transduction inhibitors estrogen receptor breast cancer progression immunomodulatory monoclonal antibodies cancer cell int

Questions {❓}

  • Are we undergoing a paradigm-shift as regards their significance in breast cancer?

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Recent development of targeted approaches for the treatment of breast cancer
         description:Breast cancer is the most prominent cause of cancer death in women worldwide. The highlights of this review are to provide an overview of the targeted therapeutic agents, challenges with metastatic breast cancer (MBCa), mechanisms of action through Hedgehog/Gli 1 signaling pathway and future prospective. Over a decade of success, several drugs have been approved and are in the advanced stages of clinical trials that target the receptors such as estrogen receptor, growth factor receptor, receptor activator of nuclear factor kappa-B, etc. Currently, several monoclonal antibodies are also used for the treatment of breast cancer. Advances in understanding tumor biology, particularly signaling pathways such as Notch signaling pathway, Hedgehog/Gli 1 signaling pathway, and inhibitors are considered to be important for bone metastasis. These studies may provide vital information for the design and development of new strategies with respect to efficacy, reduction of the side effects, and treatment strategies.
         datePublished:2016-10-31T00:00:00Z
         dateModified:2016-10-31T00:00:00Z
         pageStart:191
         pageEnd:219
         sameAs:https://doi.org/10.1007/s12282-016-0732-1
         keywords:
            Breast cancer
            Estrogen receptor
            Hedgehog/Gli 1 signaling
            Immunomodulators
            Angiogenesis
            Growth factor receptor inhibitors
            Surgical Oncology
            Oncology
            Surgery
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12282-016-0732-1/MediaObjects/12282_2016_732_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12282-016-0732-1/MediaObjects/12282_2016_732_Fig2_HTML.gif
         isPartOf:
            name:Breast Cancer
            issn:
               1880-4233
               1340-6868
            volumeNumber:24
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Japan
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:V. L. Maruthanila
               affiliation:
                     name:Institute of Advanced Study in Science and Technology
                     address:
                        name:Life Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:R. Elancheran
               affiliation:
                     name:Institute of Advanced Study in Science and Technology
                     address:
                        name:Life Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:A. B. Kunnumakkara
               affiliation:
                     name:Indian Institute of Technology
                     address:
                        name:Department of Biotechnology, Indian Institute of Technology, Guwahati, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:S. Kabilan
               affiliation:
                     name:Annamalai University
                     address:
                        name:Department of Chemistry, Annamalai University, Annamalai Nagar, India
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jibon Kotoky
               affiliation:
                     name:Institute of Advanced Study in Science and Technology
                     address:
                        name:Life Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati, India
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Recent development of targeted approaches for the treatment of breast cancer
      description:Breast cancer is the most prominent cause of cancer death in women worldwide. The highlights of this review are to provide an overview of the targeted therapeutic agents, challenges with metastatic breast cancer (MBCa), mechanisms of action through Hedgehog/Gli 1 signaling pathway and future prospective. Over a decade of success, several drugs have been approved and are in the advanced stages of clinical trials that target the receptors such as estrogen receptor, growth factor receptor, receptor activator of nuclear factor kappa-B, etc. Currently, several monoclonal antibodies are also used for the treatment of breast cancer. Advances in understanding tumor biology, particularly signaling pathways such as Notch signaling pathway, Hedgehog/Gli 1 signaling pathway, and inhibitors are considered to be important for bone metastasis. These studies may provide vital information for the design and development of new strategies with respect to efficacy, reduction of the side effects, and treatment strategies.
      datePublished:2016-10-31T00:00:00Z
      dateModified:2016-10-31T00:00:00Z
      pageStart:191
      pageEnd:219
      sameAs:https://doi.org/10.1007/s12282-016-0732-1
      keywords:
         Breast cancer
         Estrogen receptor
         Hedgehog/Gli 1 signaling
         Immunomodulators
         Angiogenesis
         Growth factor receptor inhibitors
         Surgical Oncology
         Oncology
         Surgery
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12282-016-0732-1/MediaObjects/12282_2016_732_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12282-016-0732-1/MediaObjects/12282_2016_732_Fig2_HTML.gif
      isPartOf:
         name:Breast Cancer
         issn:
            1880-4233
            1340-6868
         volumeNumber:24
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Japan
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:V. L. Maruthanila
            affiliation:
                  name:Institute of Advanced Study in Science and Technology
                  address:
                     name:Life Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:R. Elancheran
            affiliation:
                  name:Institute of Advanced Study in Science and Technology
                  address:
                     name:Life Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:A. B. Kunnumakkara
            affiliation:
                  name:Indian Institute of Technology
                  address:
                     name:Department of Biotechnology, Indian Institute of Technology, Guwahati, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:S. Kabilan
            affiliation:
                  name:Annamalai University
                  address:
                     name:Department of Chemistry, Annamalai University, Annamalai Nagar, India
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jibon Kotoky
            affiliation:
                  name:Institute of Advanced Study in Science and Technology
                  address:
                     name:Life Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati, India
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer
      issn:
         1880-4233
         1340-6868
      volumeNumber:24
Organization:
      name:Springer Japan
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Institute of Advanced Study in Science and Technology
      address:
         name:Life Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati, India
         type:PostalAddress
      name:Institute of Advanced Study in Science and Technology
      address:
         name:Life Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati, India
         type:PostalAddress
      name:Indian Institute of Technology
      address:
         name:Department of Biotechnology, Indian Institute of Technology, Guwahati, India
         type:PostalAddress
      name:Annamalai University
      address:
         name:Department of Chemistry, Annamalai University, Annamalai Nagar, India
         type:PostalAddress
      name:Institute of Advanced Study in Science and Technology
      address:
         name:Life Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati, India
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:V. L. Maruthanila
      affiliation:
            name:Institute of Advanced Study in Science and Technology
            address:
               name:Life Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati, India
               type:PostalAddress
            type:Organization
      name:R. Elancheran
      affiliation:
            name:Institute of Advanced Study in Science and Technology
            address:
               name:Life Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati, India
               type:PostalAddress
            type:Organization
      name:A. B. Kunnumakkara
      affiliation:
            name:Indian Institute of Technology
            address:
               name:Department of Biotechnology, Indian Institute of Technology, Guwahati, India
               type:PostalAddress
            type:Organization
      name:S. Kabilan
      affiliation:
            name:Annamalai University
            address:
               name:Department of Chemistry, Annamalai University, Annamalai Nagar, India
               type:PostalAddress
            type:Organization
      name:Jibon Kotoky
      affiliation:
            name:Institute of Advanced Study in Science and Technology
            address:
               name:Life Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati, India
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Life Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati, India
      name:Life Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati, India
      name:Department of Biotechnology, Indian Institute of Technology, Guwahati, India
      name:Department of Chemistry, Annamalai University, Annamalai Nagar, India
      name:Life Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati, India
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(273)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com
4.92s.